Ovarian Cancer Research Program
The OCRP funds innovative research to advance prevention, detection, treatment, and survivorship in ovarian cancer, prioritizing clinical impact and access to care for military and general populations.
Funder: Military Health System Research Program
Due Dates (Anticipated): July 2026 (Full application deadline, projected)
Funding Amounts: Multiple mechanisms; awards range from $350,000 (2 yrs, Pilot) to $2.8M (4 yrs, Clinical Trial); see details below.
Summary: Supports innovative, high-impact research to advance prevention, detection, treatment, and survivorship for ovarian cancer, with focus on military and broader populations.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
Description
The Ovarian Cancer Research Program (OCRP), administered by the Department of Defense through the Congressionally Directed Medical Research Programs (CDMRP), funds research to prevent, detect, treat, and improve outcomes for ovarian cancer. The program seeks projects with high clinical relevance and impact, spanning the development of novel therapeutic strategies, risk stratification, screening, early detection, accurate diagnosis/prognosis, improved access to quality care, survivorship, prevention, and understanding ovarian cancer biology and etiology. The FY26 cycle includes a priority on access to quality care for military personnel, veterans, and their families, but welcomes applications addressing the broader population. The program encourages collaboration, mentoring, and support for early-career investigators.
